BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38555605)

  • 21. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm.
    Yan JY; Zhang JL; Wang MQ; Yuan K; Bai YH; Wang Y; Xin HN; Wang ZJ; Liu FY; Duan F; Fu JX
    Asia Pac J Clin Oncol; 2018 Aug; 14(4):300-309. PubMed ID: 29124894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
    Kim JW; Kim JH; Won HJ; Shin YM; Yoon HK; Sung KB; Kim PN
    Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation.
    Hyun D; Cho SK; Shin SW; Rhim H; Koh KC; Paik SW
    Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1015-22. PubMed ID: 26975761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of combined therapy radiofrequency ablation/transarterial chemoembolization versus transarterial chemoembolization/radiofrequency ablation on management of hepatocellular carcinoma.
    El Dorry AK; Shaker MK; El-Fouly NF; Hussien A; El-Folly RF; El Fouly AH; Abd El Tawab K
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(12):1573-1577. PubMed ID: 32796363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching.
    Kong J; Gao R; Wu S; Shi Y; Yin T; Guo S; Xin Z; Li A; Kong X; Ma D; Zhai B; Sun W; Gao J
    Eur Radiol; 2022 May; 32(5):3309-3318. PubMed ID: 35091785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study.
    Yan L; Ren Y; Qian K; Kan X; Zhang H; Chen L; Liang B; Zheng C
    BMC Gastroenterol; 2021 Apr; 21(1):182. PubMed ID: 33879085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
    Xu RC; Liu HC; Li JL; Li K; Ou SY; Yu ZY; Kong Y; Ma GA; Shao WS
    Curr Med Res Opin; 2015 Aug; 31(8):1553-60. PubMed ID: 26067770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical efficiency of TACE combined with simultaneous computed tomography-guided radiofrequency ablation for advanced hepatocellular carcinoma.
    Yuan P; Wang F; Zhu G; Chen B
    Invest New Drugs; 2021 Oct; 39(5):1383-1388. PubMed ID: 33754235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoembolization combined radiofrequency ablation vs. chemoembolization alone for treatment of beyond the Milan criteria viable hepatocellular carcinoma (CERFA): study protocol for a randomized controlled trial.
    Lee SK; Yang H; Kwon JH; Shim DJ; Kim D; Nam SW; Yoo SH; Bae SH; Lee A; Lee YJ; Jeon C; Jang JW; Sung PS; Chun HJ; Kim SH; Choi JI; Oh JS; Yang YJ
    Trials; 2023 Mar; 24(1):234. PubMed ID: 36978150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the Efficacy Among Transcatheter Arterial Chemoembolization (TACE)-Radiofrequency Ablation Plus Apatinib, TACE Plus Apatinib, and TACE Alone for Hepatocellular Carcinoma: A Retrospective Study.
    Ouyang T; Cao Y; Chen L; Zheng C
    Cardiovasc Intervent Radiol; 2022 Jun; 45(6):780-790. PubMed ID: 35410405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of laparoscopic radiofrequency ablation versus open resection in the treatment of symptomatic-enlarging hepatic hemangiomas: a prospective study.
    Zhang X; Yan L; Li B; Wen T; Wang W; Xu M; Wei Y; Yang J
    Surg Endosc; 2016 Feb; 30(2):756-763. PubMed ID: 26123327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE).
    Iezzi R; Cesario V; Siciliani L; Campanale M; De Gaetano AM; Siciliano M; Agnes S; Giuliante F; Grieco A; Pompili M; Rapaccini GL; Gasbarrini A; Bonomo L;
    Radiol Med; 2013 Jun; 118(4):555-69. PubMed ID: 23358819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma.
    Yin X; Zhang L; Wang YH; Zhang BH; Gan YH; Ge NL; Chen Y; Li LX; Ren ZG
    BMC Cancer; 2014 Nov; 14():849. PubMed ID: 25409554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General versus local anesthesia for percutaneous radiofrequency ablation of hepatocellular carcinoma at unusual regions.
    Bai YH; Chen G; Xu Y; Cui L; Li XH; Wang XQ; Wang MQ; Duan F
    J Cancer Res Ther; 2020; 16(7):1686-1690. PubMed ID: 33565517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiofrequency ablation versus transarterial chemoembolization for unresectable solitary hepatocellular carcinomas sized 5-8 cm.
    Dai WC; Cheung TT; Chok KS; Chan AC; Sharr WW; Tsang SH; Yuen WK; Chan SC; Fan ST; Lo CM; Poon RT
    HPB (Oxford); 2015 Mar; 17(3):226-31. PubMed ID: 25284590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma.
    Li Z; Jiao D; Han X; Si G; Li Y; Liu J; Xu Y; Zheng B; Zhang X
    Cancer Imaging; 2020 Jan; 20(1):13. PubMed ID: 32000862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Angio-CT and cone-beam CT-guided immediate radiofrequency ablation after transcatheter arterial chemoembolization for large hepatocellular carcinoma.
    Yuan H; Li X; Tian X; Ji K; Liu F
    Abdom Radiol (NY); 2020 Aug; 45(8):2585-2592. PubMed ID: 32107583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curative effect of transcatheter arterial chemoembolization combined with radiofrequency ablation in treating hepatic cell carcinoma and its effect on serum markers.
    Jiang FQ; Lu W; Yang C; Du P; Ma JP; Yang J; Xie P; Zhang Z
    Cancer Biomark; 2017 Jul; 20(1):17-22. PubMed ID: 28582848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization Therapy Versus Surgical Resection for Hepatocellular Carcinoma within the Milan Criteria: A Meta-Analysis.
    Wang WD; Zhang LH; Ni JY; Jiang XY; Chen D; Chen YT; Sun HL; Luo JH; Xu LF
    Korean J Radiol; 2018; 19(4):613-622. PubMed ID: 29962868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.